코로나바이러스감염증-19(COVID-19) 관련 임상진료지침 및 신속검토 보고서입니다.
제목 | [NECA-KAMS] COVID-19 recommendations infographics (English ver.) |
---|---|
필자 | 임상근거연구팀 |
발행일 | 2023.08.25 |
조회수 | 750 |
파일 |
[NECA-KAMS]COVID-19_recommendations_infographics.pdf
바로보기 |
Pharmaceutical - Remdesivir - IL-6 inhibitor(Tocilizumab, Sarilumab) - Selective JAK inhibitor(Baricitinib, Tofacitinib, Ruxolitinib) - Monoclonal antibody therapy - Paxlovid - Molnupiravir - Steroids - Inhaled steroids - IL-1 inhibitor(Anakinra) - Specific IVIG - Convalescent plasma therapy - Non-specific IVIG - Protease inhibitors - Ivermectin - Interferon - Other antiviral agents(favipiravir, umifenovir, baloxavir marboxil) Respiratory/Intensive critical care - Therapeutic dose of anticoagulant - Early intubation - Extracorporeal membrane oxygenation (ECMO) - Positive end expiratory pressure (PEEP) - Prone position - High-flow nasal cannula (HFNC) Pediatric care - IVIG(alone or combined with steroids) for MIS-C patients - Other immunomodulators for MIS-C patients - Aspirin and anticoagulant therapy for MIS-C patients - Medications for pediatric patients(Remdesivir, Steroids, Tocilizumab, Paxlovid) Emergency care - Mechanical cardiopulmonary resuscitation Diagnostic test - Rapid antigen test (RAT) Radiological examinations - Contrast-enhanced chest CT scan - Chest X-ray follow-up - Chest CT using portable personal negative pressure isolation chamber (NPIC) |
|
공공누리/CCL |
|
이전글 | 코로나19 환자 치료를 위한 임상진료지침 (2022-2023년) |
---|---|
다음글 | 다음 글이 없습니다. |
페이지
만족도 조사
현재 페이지에 대하여 얼마나 만족하십니까?